Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04141501

Organisation Name: University of Zurich

Overal Status: Recruiting

Start Date: June 8, 2020

Last Update: July 22, 2020

Lead Sponsor: University of Zurich

Brief Summary: Effects of serotonin 2A/1A receptor stimulation by psilocybin on alcohol addicted patients: a randomized double-blind placebo-controlled study

Conditions:
  • Alcohol Use Disorder


Total execution time in seconds: 0.19527292251587